Federal Budget Misses Opportunity to Scale and Grow Health Science Companies
The 2016 Federal Liberal budget contains funding to support a much needed Innovation Agenda and promises to build globally competitive companies. At the same time the majority of this funding is directed to incubators and accelerators, granting councils and public institutions to support basic research. In order to compete in the $9 trillion global health science economy, Canada needs to devote financial resources to health science companies at the next stage of development by investing in scale up, job creation and revenue generation.
Canada shows a “disturbing” decline in innovation and R&D
Read the Canadian Business article on the recently released STIC report.
OBIO/OBEST Five Year Strategic Review: January 2015
Since its founding, the Ontario Bioscience Innovation Organization (OBIO®) has been engaged in creating the future of Ontario’s biomedical sector through industry-led strategy, policy development, advocacy and high impact programming.
OBIO Celebrates Five Years Advancing Ontario's Human Health Technology and Bioscience Ecosystem
BLG LifeSigns Article: Ontario Bioscience Innovation Organization - OBIO
Building a Fully Functional Ecosystem for Human Health Sciences in Ontario - OBIO Article in Onboard Magazine
Realizing the Promise of Healthcare Innovation in Ontario
OBIO Chair, Dr. David Young Opens OBIO AGM December 5, 2013
Interview: Gail Garland CEO, Ontario Bioscience Innovation Organization, Canada
Ontario’s Bioscience Cluster: Tapping the Untapped Potential
OBIO Reconciles Ontario Bioscience Economic Strategy (OBEST)
Ontario's Human Health Technology and Bioscience Industry gets its 'Groove Back'
OBIO Think Tank Economic Vision Document
Commercialization Success OBEST
The Ontario Bioscience Industry Strategic Implementation Plan
Ontario's Bioscience Industry - Translating Strategy into Action
The Best Laid Plans - How OBIO™ is looking to overcome the past, change the course of the bioscience industry in Ontario and steer the ship out of the storm
How OBIO(TM) is looking to overcome the past, change the course of the bioscience industry in Ontario and steer the ship out of the storm.
By: Christopher Rogers
Innovation and Bioscience go hand and hand. It is a symbiotic relationship - both depend on one another. Yet, for Ontario, a province teeming with groundbreaking initiatives in the bioscience field, there is something missing. A broken link between this would-be flourishing industry and reality. True, the recession of 2008 to 2009 hit the industry hard, but the seeds of insufficiency were planted far earlier.
For most of the past decade, the rallying cry of the Ontario life science industry has been "commercialization is key." Now, more than ever, that message rings true, but it has also evolved, and as it stands, the Ontario bioscience industry is looking for investment, incentives and the capital it needs to be the juggernaut most believe it can be. The plan to get the province to that point is what OBEST(TM), the Ontario Bioscience Economic Strategy Team hopes to bestow upon the industry.